Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Up 29.5% in March

Viemed Healthcare, Inc. (NASDAQ:VMD) was the target of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 450,066 shares, a growth of 29.5% from the February 26th total of 347,585 shares. Approximately 1.5% of the company’s stock are short sold. Based on an average daily volume of 418,682 shares, the short-interest ratio is currently 1.1 days.

Insider Transactions at Viemed Healthcare

In other news, President Michael Moore sold 65,000 shares of the company’s stock in a transaction on Friday, March 20th. The shares were sold at an average price of $8.77, for a total value of $570,050.00. Following the completion of the sale, the president owned 1,585,812 shares in the company, valued at $13,907,571.24. This represents a 3.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last three months, insiders sold 136,802 shares of company stock worth $1,237,976. 20.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue purchased a new stake in shares of Viemed Healthcare in the fourth quarter worth $25,000. Kemnay Advisory Services Inc. bought a new position in Viemed Healthcare in the 4th quarter worth about $46,000. Quarry LP bought a new position in Viemed Healthcare in the 3rd quarter worth about $48,000. AQR Capital Management LLC purchased a new stake in shares of Viemed Healthcare in the 1st quarter valued at about $90,000. Finally, SG Americas Securities LLC bought a new stake in shares of Viemed Healthcare during the 4th quarter valued at about $101,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Performance

Viemed Healthcare stock traded down $0.12 during midday trading on Tuesday, reaching $9.23. The stock had a trading volume of 167,992 shares, compared to its average volume of 242,932. Viemed Healthcare has a 12 month low of $5.93 and a 12 month high of $10.06. The firm’s 50-day moving average price is $8.53 and its 200 day moving average price is $7.48. The firm has a market capitalization of $356.28 million, a PE ratio of 24.95 and a beta of 1.23. The company has a quick ratio of 1.06, a current ratio of 1.18 and a debt-to-equity ratio of 0.08.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.02. The firm had revenue of $76.18 million during the quarter, compared to analyst estimates of $77.70 million. Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%.

Analyst Ratings Changes

A number of research firms have weighed in on VMD. Zacks Research raised shares of Viemed Healthcare to a “hold” rating in a research report on Thursday, January 8th. Wall Street Zen raised shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 14th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Viemed Healthcare in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold”.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.